Literature DB >> 16525881

Deep gray matter and fatigue in MS: a T1 relaxation time study.

G Niepel1, Ch R Tench, P S Morgan, N Evangelou, D P Auer, C S Constantinescu.   

Abstract

UNLABELLED: Fatigue in multiple sclerosis (MS) occurs commonly, sometimes as the earliest symptom. Some MS patients consider fatigue to be their most troublesome complaint, and it has been shown to be an independent predictor of impaired quality of life. Several reports have demonstrated that subcortical gray matter pathology is related to fatigue. We hypothesized that MRI detectable changes in the deep gray matter of MS patients may correlate with fatigue severity. Our objective was: to assess the relationship between fatigue severity and detectable changes on magnetic resonance imaging (MRI), quantified using the mean T1 relaxation time (T1), in deep gray matter structures in relapsing remitting multiple sclerosis (RRMS). Using region of interest analysis, T1 values were measured for the thalamus, putamen and caudate nucleus in 52 RRMS patients and 19 healthy volunteers. Fatigue was assessed using the Fatigue Severity Scale.
RESULTS: The median T1 in the thalamus and the putamen were significantly higher in the patient cohort than in the healthy controls; the median T1 in the caudate was also higher in the MS patients but did not reach statistical significance. There was a significant correlation between fatigue severity and the T1 of the thalamus (rho = 0.418; p = 0.014). Furthermore, the median T1 in the thalamus was significantly higher in patients with fatigue compared with those without (p = 0.018). Our results provide further evidence for the role of subcortical gray matter structures in the pathogenesis of multiple sclerosis (MS)-related fatigue. This study also demonstrates that T1 relaxation time measurement is a suitable technique for detecting abnormalities of the deep gray matter in RRMS and presents further support of gray matter involvement in MS.

Entities:  

Mesh:

Year:  2006        PMID: 16525881     DOI: 10.1007/s00415-006-0128-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

Authors:  L Truyen; J H van Waesberghe; M A van Walderveen; B W van Oosten; C H Polman; O R Hommes; H J Adèr; F Barkhof
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

3.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

4.  Fatigue and magnetic resonance imaging activity in multiple sclerosis.

Authors:  C Mainero; J Faroni; C Gasperini; M Filippi; E Giugni; O Ciccarelli; M Rovaris; S Bastianello; G Comi; C Pozzilli
Journal:  J Neurol       Date:  1999-06       Impact factor: 4.849

5.  Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology?

Authors:  R L Bruno; S J Creange; N M Frick
Journal:  Am J Med       Date:  1998-09-28       Impact factor: 4.965

6.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

7.  Disability rating scales in multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

8.  Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach.

Authors:  Lalitha Vaithianathar; Chris R Tench; Paul S Morgan; Cris S Constantinescu
Journal:  J Neurol       Date:  2003-03       Impact factor: 4.849

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Authors:  M Wylezinska; A Cifelli; P Jezzard; J Palace; M Alecci; P M Matthews
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  27 in total

Review 1.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

Review 2.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 4.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

5.  Cognitive fatigue defined in the context of attention networks.

Authors:  Roee Holtzer; Melissa Shuman; Jeannette R Mahoney; Richard Lipton; Joe Verghese
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-10-10

6.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

Review 7.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

8.  The basal ganglia: a substrate for fatigue in multiple sclerosis.

Authors:  N Téllez; J Alonso; J Río; M Tintoré; C Nos; X Montalban; A Rovira
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

9.  Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.

Authors:  Amanda F Mejia; Elizabeth M Sweeney; Blake Dewey; Govind Nair; Pascal Sati; Colin Shea; Daniel S Reich; Russell T Shinohara
Journal:  Neuroimage       Date:  2015-12-28       Impact factor: 6.556

10.  Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration.

Authors:  Khader M Hasan; Christopher Halphen; Arash Kamali; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2009-01       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.